CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:CTRVP

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/07/16	06:17	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/07/11	22:46	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/03/08	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/03/07	06:30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/22	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/22	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/21	06:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2024/02/08	06:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/12/07	22:41	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/28	20:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/21	05:59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/11/01	05:15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/10/04	06:22	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/10/03	05:52	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/09/21	00:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/09/19	22:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/08/15	05:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/07/15	06:12	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/05/13	05:19	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/04/11	05:52	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2023/04/03	19:02	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/22	07:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/15	06:38	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/10	07:21	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/11/09	20:07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/10/18	06:14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/08/06	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/27	05:06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/25	20:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/07/05	21:34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)